Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 9:36 PM
Study NCT ID:
NCT07343856
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2026-01-15
First Post:
2025-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long COVID Diagnostic Reactivity Assesment Test
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2026-03-25'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000094024', 'term': 'Post-Acute COVID-19 Syndrome'}, {'id': 'D054969', 'term': 'Primary Dysautonomias'}], 'ancestors': [{'id': 'D000086382', 'term': 'COVID-19'}, {'id': 'D011024', 'term': 'Pneumonia, Viral'}, {'id': 'D011014', 'term': 'Pneumonia'}, {'id': 'D012141', 'term': 'Respiratory Tract Infections'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018352', 'term': 'Coronavirus Infections'}, {'id': 'D003333', 'term': 'Coronaviridae Infections'}, {'id': 'D030341', 'term': 'Nidovirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D000094025', 'term': 'Post-Infectious Disorders'}, {'id': 'D002908', 'term': 'Chronic Disease'}, {'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D001342', 'term': 'Autonomic Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'DIAGNOSTIC', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'All enrolled participants undergo a single-session diagnostic assessment using medicament testing to evaluate bioelectrical response patterns associated with viral persistence.'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 50}}, 'statusModule': {'overallStatus': 'ENROLLING_BY_INVITATION', 'startDateStruct': {'date': '2025-12-05', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-12', 'completionDateStruct': {'date': '2027-01-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2026-01-07', 'studyFirstSubmitDate': '2025-12-24', 'studyFirstSubmitQcDate': '2026-01-07', 'lastUpdatePostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-12-30', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of Participants With Bioelectrical Response Patterns Consistent With Viral Persistence', 'timeFrame': 'At enrollment (single diagnostic session)', 'description': 'Non-invasive diagnostic assessment using electroacupuncture-based medicament testing to identify bioelectrical response patterns consistent with viral antigen persistence in participants with post-viral conditions.'}], 'secondaryOutcomes': [{'measure': 'Distribution of Bioelectrical Reactivity Patterns During Medicament Testing', 'timeFrame': 'Baseline(Day 1)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Long COVID', 'Post-acute sequelae of SARS-CoV-2 infection', 'Bioelectrical assessment', 'Electroacupuncture diagnostics', 'Medicament testing', 'Autonomic dysregulation', 'Chronic viral persistence', 'Non-invasive diagnostics'], 'conditions': ['Long COVID', 'Post-Acute Sequelae of SARS-CoV-2 Infection']}, 'descriptionModule': {'briefSummary': 'This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.\n\nThe method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.\n\nThe study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.', 'detailedDescription': 'This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing.\n\nThe method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.\n\nThe study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '75 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Age 18 years or older\n* History of confirmed SARS-CoV-2 infection\n* Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection\n* Ability to provide informed consent\n* Willingness to undergo non-invasive bioelectrical diagnostic assessment\n\nExclusion Criteria:\n\n* Acute infectious disease at the time of enrollment\n* Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment\n* Implanted electronic medical devices (e.g., pacemaker)\n* Pregnancy or breastfeeding\n* Inability to comply with study procedures'}, 'identificationModule': {'nctId': 'NCT07343856', 'acronym': 'EAV-LONGCOVID', 'briefTitle': 'Long COVID Diagnostic Reactivity Assesment Test', 'organization': {'class': 'OTHER', 'fullName': 'Oncology Center,Ministry Of Heath,Uzbekistan'}, 'officialTitle': 'Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID', 'orgStudyIdInfo': {'id': '9/36-2216'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Diagnostic Assesment Arm', 'description': 'This single-arm study includes participants undergoing a non-invasive electrodiagnostic assessment to evaluate bioelectrical response patterns associated with viral antigen persistence. No therapeutic intervention is administered.', 'interventionNames': ['Diagnostic Test: Electrodiagnostic Bioelectrical Assessment']}], 'interventions': [{'name': 'Electrodiagnostic Bioelectrical Assessment', 'type': 'DIAGNOSTIC_TEST', 'description': 'A non-invasive diagnostic procedure performed during a single session to assess bioelectrical response patterns associated with viral antigen persistence. Measurements are obtained using standardized bioelectrical assessment techniques without administration of any therapeutic agents or interventions.', 'armGroupLabels': ['Diagnostic Assesment Arm']}]}, 'contactsLocationsModule': {'locations': [{'zip': '100194', 'city': 'Tashkent', 'country': 'Uzbekistan', 'facility': 'Research Institute of Virology', 'geoPoint': {'lat': 41.26465, 'lon': 69.21627}}], 'overallOfficials': [{'name': 'Naylya Djumaeva, MD,PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Reseacrh Institute of Virology'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Oncology Center,Ministry Of Heath,Uzbekistan', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}